A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : DCEP / dexamethasone, cyclophosphamide, etoposide, and cisplatin

[Related PubMed/MEDLINE]
Total Number of Papers: 15
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   DCEP  (>> Co-occurring Abbreviation)
Long Form:   dexamethasone, cyclophosphamide, etoposide, and cisplatin
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 DCEP and bendamustine/prednisone as salvage therapy for quad- and penta-refractory multiple myeloma. BP, DOR, MM, ORR, OS, PFS
2019 Efficacy of conventional chemotherapy in a primary double-refractory IgM multiple myeloma. VGPR
2018 DCEP as a bridge to ongoing therapies for advanced relapsed and/or refractory multiple myeloma. ASCT, ORR, OS, RRMM, TRM
2015 A comparison of salvage infusional chemotherapy regimens for recurrent/refractory multiple myeloma. CVAD
2014 DCEP for relapsed or refractory multiple myeloma after therapy with novel agents. TRM
2011 Results of the first bortezomib-based induction therapy in the treatment of multiple myeloma. BD, CR, MM, PFS, VAD
2010 Bortezomib plus dexamethasone can improve stem cell collection and overcome the need for additional chemotherapy before autologous transplant in patients with myeloma. ISS, MM, ORR, VGPR
2010 Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial. PFS, VAD, VGPR
2007 Dexamethasone, cyclophosphamide, etoposide and cisplatin (DCEP) for relapsed or refractory multiple myeloma patients. ASCT, CR, MM, OR, PR
10  2005 Efficacy, toxicity and feasibility of a shorter schedule of DCEP regimen for stem cell mobilization in multiple myeloma. infusional-DCEP
11  2005 Malignant pleural effusion of multiple myeloma: prognostic factors and outcome. B2M, CRP, MM, MPE
12  2004 The VAD-DCEP sequence is an effective pre-transplant therapy in untreated multiple myeloma. PBSC
13  2002 A combination of dexamethasone, cyclophosphamide, etoposide, and cisplatin is less toxic and more effective than high-dose cyclophosphamide for peripheral stem cell mobilization in multiple myeloma. HD-CY, MM, PBSC
14  2001 DCEP (dexamethasone, cyclophosphamide, etoposide, and cisplatin) is an effective regimen for peripheral blood stem cell collection in multiple myeloma. ---
15  2001 High-dose therapy and innovative approaches to treatment of multiple myeloma. MM, MRI